Description
Description and Effects
OZEMPIC (Semaglutide 1 mg Pen, 4 mg / 3 mL) is a GLP-1 receptor agonist formulated to support effective and sustainable weight loss. Each pen contains 4 mg of semaglutide in 3 mL solution (1.34 mg/mL), allowing precise weekly dosing. By mimicking the natural incretin hormone, it reduces appetite, increases satiety, and helps stabilize blood sugar levels, promoting gradual fat loss while preserving lean muscle mass.
Product Benefits
- Accelerated Fat Loss: Suppresses hunger and reduces caloric intake, facilitating consistent fat reduction.
- Improved Appetite Control: Diminishes cravings, making it easier to maintain a calorie deficit.
- Enhanced Energy and Focus: Stabilizes blood sugar levels, preventing energy crashes during dieting phases.
- Once-Weekly Dosing: Convenient, discreet, and long-acting injection for consistent weight management.
Usage Guidelines
- Recommended Dosage: 1 mg injected subcutaneously once per week, preferably on the same day each week.
- Administration Site: Inject into the abdomen, thigh, or upper arm; rotate sites to avoid irritation.
- Dietary Notes: For optimal results, combine with a balanced, calorie-controlled diet and regular physical activity.
Precautions and Wellness
- Possible Side Effects: May include nausea, stomach discomfort, constipation, or fatigue during initial weeks.
- Hydration & Nutrition: Maintain adequate water intake and avoid skipping meals while on treatment.
- Medical Caution: Not recommended for individuals with a history of thyroid cancer, pancreatitis, or severe gastrointestinal disorders.
- Responsible Use: For prescribed therapeutic use only; always follow dosage recommendations and medical guidance.
